戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y, tolerance, and efficacy of fluoxetine for hypochondriasis.
2 ley Hypochondriasis Index was used to assess hypochondriasis.
3 eficial long-term effects on the symptoms of hypochondriasis.
4  be part of the cognitive distortion seen in hypochondriasis.
5  prospective case-control study of DSM-III-R hypochondriasis.
6  demographically matched individuals without hypochondriasis.
7 ividuals from the general population without hypochondriasis.
8 he Whiteley Hypochondriasis Index indicating hypochondriasis.
9  demographically matched individuals without hypochondriasis (23 420 women [56.7%]; median age at mat
10                 Of the 4129 individuals with hypochondriasis (2342 women [56.7%]; median age at first
11                                              Hypochondriasis, also known as health anxiety disorder,
12 2 years]) in the study, 268 individuals with hypochondriasis and 1761 individuals without hypochondri
13                                              Hypochondriasis and adverse life events double the risk
14 cantly more effective at week 24 in reducing hypochondriasis and had a significantly faster rate of i
15  of inflammation, female gender, depression, hypochondriasis, and adverse life events in the precedin
16 me to recovery: humor, acting out, emotional hypochondriasis, and projection.
17 oblems, Tenth Revision (ICD-10) diagnosis of hypochondriasis assigned between January 1, 1997, and De
18                                              Hypochondriasis, but not mood or anxiety disorders, was
19 ortality was observed among individuals with hypochondriasis compared with individuals without hypoch
20 patients meeting DSM diagnostic criteria for hypochondriasis completed an extensive research battery
21                             Prior studies of hypochondriasis demonstrated benefits for pharmacotherap
22 hypochondriasis and 1761 individuals without hypochondriasis died during the study period, correspond
23 of movements, and a psychiatric diagnosis of hypochondriasis, factitious disorder, or malingering are
24 he Yale-Brown Obsessive Compulsive Scale for hypochondriasis (H-YBOCS-M).
25  cohort study suggests that individuals with hypochondriasis have an increased risk of death from bot
26 hondriasis compared with individuals without hypochondriasis (HR, 1.69; 95% CI, 1.47-1.93).
27                Validated ICD-10 diagnoses of hypochondriasis in the National Patient Register.
28 , and 7% (n = 12) had scores on the Whiteley Hypochondriasis Index indicating hypochondriasis.
29 mood and anxiety disorders, and the Whiteley Hypochondriasis Index was used to assess hypochondriasis
30                                              Hypochondriasis is a chronic, distressing, and disabling
31 hors' goal was to assess the degree to which hypochondriasis is accompanied by a heightened sense of
32                                     Although hypochondriasis is generally thought to be a chronic and
33 The risk of mortality among individuals with hypochondriasis is unknown.
34  morbidity is common in this population, and hypochondriasis may account for a significant proportion
35 rmed, cognitive and behavioral therapies for hypochondriasis may need to include a focus on these pat
36                 METHOD: Patients with DSM-IV hypochondriasis (N=195) were randomly assigned to one of
37                         Evaluations assessed hypochondriasis, other psychopathology, adverse events,
38 our immature defenses (acting out, emotional hypochondriasis, passive aggression, and projection), an
39 m exceeded a predetermined cutoff score on a hypochondriasis self-report questionnaire on 2 successiv
40                                              Hypochondriasis, therefore, carries a very substantial,
41 -six patients meeting DSM-III-R criteria for hypochondriasis were compared with 127 nonhypochondriaca
42              Agitation, psychic anxiety, and hypochondriasis were more severe in the nonattempter gro